Novel Structurally-Modified Allosteric Effectors of Hemoglobin Exhibit Superior Antisickling Properties
Osheiza Abdulmalik(Children's Hospital of Philadelphia), Martin K. Safo(Virginia Commonwealth University), Tanvi Deshpande(Virginia Commonwealth University), Mohini S. Ghatge(Children's Hospital of Philadelphia), Yan Zhang(Virginia Commonwealth University), Jürgen Venitz(National Cancer Institute), Apurvasena Parikh(AbbVie (United States))
Cited by 2
Related Papers
In vivo hematopoietic stem cell modification by mRNA delivery
|Science|2023|321
2‐Methoxyestradiol, a Promising Anticancer Agent
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2003|276
5‐hydroxymethyl‐2‐furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells<sup>†,‡</sup>
|British Journal of Haematology|2005|244
Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia
|Nature Communications|2016|212
G Protein–Coupled Receptor Deorphanizations
|The Annual Review of Pharmacology and Toxicology|2011|193